Wednesday, July 8, 2026

pharma · Gastroesophageal Reflux · Migraine · ADXN

Addex Therapeutics

Addex Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

GENEVA, V8, CH HQ
2002 Founded
21 Employees
Public company Type
ADXN · NYSE Ticker
Company details
Status
Public
HQ
GENEVA, V8, CH
Founded
2002
Employees
21
Programs
6
Drugs
3
Patents
40
Intelligence · Clinical Trials

Addex Therapeutics clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to Addex Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Addex Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Addex Therapeutics.

  1. ADX10059 — Phase 2

    Clinical update
  2. Dipraglurant — Phase 3

    Clinical update
  3. ADX48621 — Phase 2

    Clinical update
  4. ADX10059 — Phase 2

    Clinical update
  5. Dipraglurant — Phase 2

    Clinical update
  6. ADX48621 — Phase 1

    Clinical update

Trial registry

8 studies